Oral Disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels

Diabetes Care

Volumn 32, Issue 2, 2009, Pages 335-341

  Utzschneider, Kristina M ^a,b   Prigeon, Ronald L ^c,d   Faulenbach, Mirjam V ^a,b   Tong, Jenny ^a,b   Carr, Darcy B ^e   Boyko, Edward J ^a   Leonetti, Donna L ^b   McNeely, Marguerite J ^b   Fujimoto, Wilfred Y ^b   Kahn, Steven E ^b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; BLOOD; DIET RESTRICTION; FEEDBACK SYSTEM; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLISM; METHODOLOGY; PANCREAS ISLET BETA CELL; PHYSIOLOGY; PREDICTION AND FORECASTING; REGRESSION ANALYSIS; REPRODUCIBILITY; SECRETION; TIME;

BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEEDBACK; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 61849106040     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1478     Document Type: Article

References (25)

1. Kahn SE: The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19, 2003
2. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467, 1981
3. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al.: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
4. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51: 2796-2803, 2002
5. Ehrmann DA, Sturis J, Byrne MM, Karri- son T, Rosenfield RL, Polonsky KS: Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin- dependent diabetes mellitus. J Clin Invest 96:520-527, 1995
6. Utzschneider KM, Prigeon RL, Carr DB, Hull RL, Tong J, Shofer JB, Retzlaff BM, Knopp RH, Kahn SE: Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29:356-362, 2006
7. Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, Groop L: Parallel manifestation of insulin resistance and β-cell decompensation is compatible with a common defect in type 2 diabetes. Diabetologia 47:782-793, 2004
8. Stumvoll M, Tataranni PA, Stefan N, Vozarova B, Bogardus C: Glucose allostasis. Diabetes 52:903-909, 2003
9. Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA: Coordinate changes in plasma glucose and pancreatic β-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074-1079, 2006
10. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, Goico J, Ochoa C, Azen SP: Response of pancreatic β -cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 49:782-788, 2000
11. Utzschneider KM, Prigeon RL, Tong J, Gerchman F, Carr DB, Zraika S, Uda- yasankar J, Montgomery B, Mari A, Kahn SE: Within-subject variabilityofmeasures of β -cell function derived froma2h OGTT: implications for research studies. Diabetologia 50:2516-2525, 2007
12. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D: TCF7L2 polymorphisms and progressionto diabetes in the Diabetes Prevention Program. N Engl J Med 355:241-250, 2006
13. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H: Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effects of lifestyle intervention and metformin. Diabetes 54:2404-2414, 2005
14. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B: Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16:1901-1907, 2008
15. Sakaue S, Ishimaru S, Ikeda D, Ohtsuka Y, Honda T, Suzuki J, Kawakami Y, Ishii J, Nishimura M: Estimation of i -cell function from the data of the oral glucose tolerance test. Am J Physiol Endocrinol Metab 292:E1575-E1580, 2007
16. Riggs DS, Guarnieri JA, Addeman S: Fitting straight lines when both variables are subject to error. Life Sci 22:1305-1360, 1978
17. Hayashi T, Boyko EJ, Leonetti DL, Mc- Neely MJ, Newell-Morris L, Kahn SE, Fu- jimoto WY: Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 26:650 -655, 2003
18. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
19. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192, 1998
20. The R Development Core Team: A Language and Environment for Statistical Computing, Reference Index [Internet], 2005. version 2.1.1. Vienna, Austria, R Foundation for Statistical Computing. Available from http://www.R-project.org. Accessed 15 September 2007
21. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
22. Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE: Progressive loss of β -cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 30:677-682, 2007
23. Armitage P, Berry G, Matthews J: Statistical Methods in Medical Research. Oxford, Blackwell Science, 2002
24. Kautzky-Willer A, Thomaseth K, Clodi M, Ludvik B, Waldhausl W, Prager R, Pacini G: β -cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 45:486 -491, 1996
25. Rudovich NN, Rochlitz HJ, Pfeiffer AF: Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 53:2359-2365, 2004